Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02986984Recruiting

Transformative Research in Diabetic Nephropathy

Role: collaborator

NCT05780918Not ApplicableActive Not Recruiting

A Communication Tool to Improve Communication in the ICU

Role: collaborator

NCT01920737Phase 2Active Not Recruiting

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Role: collaborator

NCT06373107Not ApplicableTerminated

Investigating Effects of High-intensity Gait Training on Gait, Balance and Depression Post-stroke

Role: collaborator

All 4 trials loaded